Executive committee members Lee Heeson and Gregory Oakes to leave the company for personal reasons
Succession planning ongoing
ST. GALLEN, Switzerland -- (BUSINESS WIRE) --
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced changes to its Executive Committee as current members Lee Heeson, President International, and Gregory Oakes, President North America, have decided to leave the company for personal reasons. Succession planning is currently underway and will be announced once the process has been concluded.
In parallel to these management changes, Vifor Pharma is pleased that Molly Painter is joining the company as President U.S., effective as of 18 October 2021. Molly has a proven track record of building and leading organizations across multiple therapeutic areas, and extensive experience in launching and commercializing products in the U.S..
Abbas Hussain, Chief Executive Officer of Vifor Pharma Group, commented: “I am delighted to welcome Molly Painter to Vifor Pharma. She brings a wealth of experience with over 20 years in the healthcare industry. I want to thank Lee and Greg for their contributions to Vifor Pharma and to the Executive Committee, especially for their commitment and leadership of the organization during the COVID-19 pandemic. I wish them the very best for their future endeavours, both professionally and personally.”
About Vifor Pharma Group
Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care). Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).
芯原与新基讯联合推出5G RedCap/4G LTE
研究显示,HK L-137可减轻健康超重个体的炎症
吉列推出“吉列杯”锦标赛
可复制领导力千企走戈壁玄奘之路戈壁徒步挑战
CEM领域黑马入局 策云科技完成千万级天使轮融
新东方在线公益巡讲陕西站:筑梦起航,强词有
MSCI宣布与Royalty Pharma结成战略联盟
车神·经 广汽设计师在传祺新M8上玩嗨了?
Sportradar宣布首次公开发行的定价
滨城区清怡小学语文组线上集体教研
博莱克威奇报告:将可再生能源纳入电网
韦纳奇谷学院评估当地大学受勒索软件攻击后的
守住一社区护住一座城 应援首都社区战疫共同
Andersen Global巩固加勒比业务版图
东芝存储器控股公司任命Lorenzo A
Johnson & Johns
迪拜将举办2024 World Cities
CSC研究发现第三方组织持续为数千个新冠疫情
周大福珠宝集团与陕西历史博物馆、西北工业大
尖端ArF浸液光刻光源“GT66A”正式量产出货
SINOVAC报告其抗新冠病毒抗体SA55注射液
ABB shareholders approve
飞行梦不易,考飞行执照如何选择靠谱的飞行俱
Nanox宣布规模扩大后的首次公开发行的定价